Can sorafenib be discontinued in hepatocellular carcinoma patients with a complete response to treatment?

著录项

• 来源
  《肝癌研究（英文版）》 |2015年第3期|109-110|共2页
• 作者

  Jing Li; Liang Huang; Yi-Qun Yan;

  展开▼
• 作者单位

  Department of Hepatic Surgery I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;

  Department of Hepatic Surgery I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;

  Department of Hepatic Surgery I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词

• 入库时间 2022-08-19 03:37:55